Tuesday, September 23, 2014 1:38:46 PM
Ebola Could Infect 1.4 Million People by End of January, CDC Projects
Sep 23, 2014, 11:57 AM ET
By SYDNEY LUPKIN
SYDNEY LUPKIN More From Sydney »
Health Reporter
PHOTO: A member of a volunteer medical team wears protective glasses before burying the body of an Ebola victim in Conakry, Guinea on Sept. 13, 2014.
A member of a volunteer medical team wears protective glasses before burying the body of an Ebola victim in Conakry, Guinea on Sept. 13, 2014. Mamadou Cellou Diallo/Getty Images
[[color=red]b]Without the proper intervention, the Ebola outbreak could reach 1.4 million cases by the end of January, according to new estimates from the U.S. Centers for Disease Control and Prevention. [/color]
That means there could be 21,000 new cases by the end of this month alone.
The CDC created a mathematical model to determine how the West African Ebola outbreak will play out depending on different intervention scenarios, taking into account that current Ebola case counts are "vastly" under-reported, as health officials have been saying since August.
"The CDC estimates are staggering," said ABC News Chief Health and Medical Editor Dr. Richard Besser. "While this is a disaster for West Africa, it is also a disaster for the United States and the rest of the world."
According to the World Health Organization, 5,357 Ebola cases have been reported since the outbreak began in West Africa six months ago, including 2,630 deaths. But the organization last month warned that people are hiding their infected family members and burying their dead in secret, leading to "shadow zones" and "invisible caseloads." The CDC's estimates for reported case counts, if current trends continue, are 8,000 by the end of this month and 550,000 by the end of January.
Though there have only been a handful of Americans who have contracted Ebola -- all while working in West Africa -- Besser said the outbreak is a problem for the global community.
"Germs tend to travel," Besser said. "More people sick in Africa increases the chances that the disease will get imported to America. While it won't spread here, any transmission in the U.S. will be for many people, quite terrifying."
Although things look grim if nothing changes, the agency predicted that intervention can make a huge difference.
If 70 percent of Ebola patients are placed in Ebola treatment centers or home settings that reduce transmission by December, the outbreak could be nearly over by the end of January, according to the CDC. However, every month that intervention is delayed means more cases and a slower stop to the outbreak.
"If conditions continue without scale-up of interventions, cases will continue to double approximately every 20 days, and the number of cases in West Africa will rapidly reach extraordinary levels," the report reads.
The CDC study authors concluded that more beds, staff and other treatment resources are needed to curb the outbreak.
http://abcnews.go.com/Health/ebola-infect-14-million-people-end-january-cdc/story?id=25698878
Sep 23, 2014, 11:57 AM ET
By SYDNEY LUPKIN
SYDNEY LUPKIN More From Sydney »
Health Reporter
PHOTO: A member of a volunteer medical team wears protective glasses before burying the body of an Ebola victim in Conakry, Guinea on Sept. 13, 2014.
A member of a volunteer medical team wears protective glasses before burying the body of an Ebola victim in Conakry, Guinea on Sept. 13, 2014. Mamadou Cellou Diallo/Getty Images
[[color=red]b]Without the proper intervention, the Ebola outbreak could reach 1.4 million cases by the end of January, according to new estimates from the U.S. Centers for Disease Control and Prevention. [/color]
That means there could be 21,000 new cases by the end of this month alone.
The CDC created a mathematical model to determine how the West African Ebola outbreak will play out depending on different intervention scenarios, taking into account that current Ebola case counts are "vastly" under-reported, as health officials have been saying since August.
"The CDC estimates are staggering," said ABC News Chief Health and Medical Editor Dr. Richard Besser. "While this is a disaster for West Africa, it is also a disaster for the United States and the rest of the world."
According to the World Health Organization, 5,357 Ebola cases have been reported since the outbreak began in West Africa six months ago, including 2,630 deaths. But the organization last month warned that people are hiding their infected family members and burying their dead in secret, leading to "shadow zones" and "invisible caseloads." The CDC's estimates for reported case counts, if current trends continue, are 8,000 by the end of this month and 550,000 by the end of January.
Though there have only been a handful of Americans who have contracted Ebola -- all while working in West Africa -- Besser said the outbreak is a problem for the global community.
"Germs tend to travel," Besser said. "More people sick in Africa increases the chances that the disease will get imported to America. While it won't spread here, any transmission in the U.S. will be for many people, quite terrifying."
Although things look grim if nothing changes, the agency predicted that intervention can make a huge difference.
If 70 percent of Ebola patients are placed in Ebola treatment centers or home settings that reduce transmission by December, the outbreak could be nearly over by the end of January, according to the CDC. However, every month that intervention is delayed means more cases and a slower stop to the outbreak.
"If conditions continue without scale-up of interventions, cases will continue to double approximately every 20 days, and the number of cases in West Africa will rapidly reach extraordinary levels," the report reads.
The CDC study authors concluded that more beds, staff and other treatment resources are needed to curb the outbreak.
http://abcnews.go.com/Health/ebola-infect-14-million-people-end-january-cdc/story?id=25698878
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
